Douwe Pons

925 citations

26 papers · 653 · h-index 14

Impact in

Nephrology top 10%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Hematology
- Blood Coagulation and Thrombosis Mechanisms

Papers in

Surgery 9
- Coronary Interventions and Diagnostics 7
- Lipoproteins and Cardiovascular Health 3
Cardiology and Cardiovascular Medicine 9
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Acute Myocardial Infarction Research 4

Co-authors: J. Wouter Jukema (22 shared papers)Paul H.A. Quax (8 shared papers)F. R. de Vries (2 shared papers)Peter J. van den Elsen (2 shared papers)Bastiaan T. Heijmans (1 shared paper)JM Tavaré (1 shared paper)René A. Tio (10 shared papers)Peter W. Mathieson (1 shared paper)
Journals: Pharmacogenetics and Genomics (2 papers)European Heart Journal (2 papers)Disease Markers (2 papers)Thrombosis and Haemostasis (1 paper)Heart (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

Douwe Pons

26 papers receiving 641 citations

Peers

Countries citing papers authored by Douwe Pons

Since Specialization

Citations

This map shows the geographic impact of Douwe Pons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douwe Pons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douwe Pons more than expected).

Fields of papers citing papers by Douwe Pons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douwe Pons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douwe Pons. The network helps show where Douwe Pons may publish in the future.

Co-authors

The 25 scholars most cited alongside Douwe Pons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douwe Pons Line = papers co-authored together Douwe Pons links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease European Heart Journal ·Douwe Pons, F. R. de Vries, Peter J. van den Elsen, Bastiaan T. Heijmans, Paul H.A. Quax, J. Wouter Jukema	2008	147
2	Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy Nephrology Dialysis Transplantation ·Rachel Lennon, Douwe Pons, Matthew A. Sabin, Chen Wei, (unknown), Richard J. Coward, JM Tavaré, Peter W. Mathieson, Moin A. Saleem, Gavin I. Welsh	2009	126
3	Interleukin‐1β and interleukin‐1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non‐asthmatic subjects Clinical & Experimental Allergy ·Josephine de Kluijver, Katrien Grünberg, Douwe Pons, E.P.A. de Klerk, Claire R. Dick, Peter Sterk, Pieter S. Hiemstra	2003	47
4	Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality Stroke Research and Treatment ·Stella Trompet, Douwe Pons, Sandip M. Kanse, Anton J.M. de Craen, M. Arfan Ikram, Jeffrey J. W. Verschuren, Aeilko H. Zwinderman, Pieter A. Doevendans, René A. Tio, Robbert J. de Winter, P. Eline Slagboom, Rudi G. J. Westendorp, J. Wouter Jukema	2011	39
5	Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention Expert Opinion on Therapeutic Targets ·Pascalle S. Monraats, Yue Fang, Douwe Pons, Nuno MM Pires, Huibert A. P. Pols, Aeilko H. Zwinderman, Moniek PM de Maat, Pieter AF Doevendans, Robbert DeWinter, René A. Tio, Johannes Waltenberger, Rune R. Frants, Paul H.A. Quax, Arnoud van der Laarse, Ernst E. van der Wall, André G. Uitterlinden, J. Wouter Jukema	2010	34
6	Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention Genes and Immunity ·Pascalle S. Monraats, F. A. S. Kurreeman, Douwe Pons, Varsha D. K. D. Sewgobind, F. R. de Vries, A. H. Zwinderman, Moniek P.M. de Maat, Pieter A. Doevendans, Robbert J. de Winter, René A. Tio, Johannes Waltenberger, T. Huizinga, D. Eefting, Paul H.A. Quax, Rune R. Frants, Arnoud van der Laarse, Ernst E. van der Wall, J. Wouter Jukema	2006	28
7	Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions Human Mutation ·Goran Rudež, Douwe Pons, Frank W.G. Leebeek, Pascalle S. Monraats, Marlies Schrevel, Aeilko H. Zwinderman, Robbert de Winter, René A. Tio, Pieter A. Doevendans, J. Wouter Jukema, Moniek P.M. de Maat	2008	27
8	p27 ^kip1 –838C>A Single Nucleotide Polymorphism Is Associated With Restenosis Risk After Coronary Stenting and Modulates p27 ^kip1 Promoter Activity Circulation ·Claudia M. van Tiel, Peter I. Bonta, Saskia Z.H. Rittersma, Marcel A.M. Beijk, Eddie Bradley, Anita Klous, Karel T. Koch, Frank Baas, J. Wouter Jukema, Douwe Pons, M. Lourdes Sampietro, Hans Pannekoek, Robbert J. de Winter, Carlie J.M. de Vries	2009	25
9	The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity Thrombosis Research ·Michael Etscheid, Lars Muhl, Douwe Pons, J. Wouter Jukema, Herbert König, Sandip M. Kanse	2012	25
10	Localization of mRNA Expression of P‐Glycoprotein at the Blood‐Brain Barrier and in the Hippocampus Annals of the New York Academy of Sciences ·A.M. Karssen, Onno C. Meijer, Douwe Pons, E. R. de Kloet	2004	24
11	Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial BMC Geriatrics ·E.J.M. Schrijver, Oscar J. de Vries, Astrid Verburg, Karola de Graaf, Pierre M. Bet, Peter M. van de Ven, Ad Kamper, Sabine Ha Diepeveen, Sander Anten, Andrea Siegel, Esther Kuipéri, A. Margot Lagaay, Rob J. van Marum, Astrid M. van Strien, Leo Boelaarts, Douwe Pons, Mark H.H. Kramer, Prabath W.B. Nanayakkara	2014	22
12	Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies Heart ·Douwe Pons, Stella Trompet, Anton J. M. de Craen, Peter Thijssen, Paul H.A. Quax, Margreet R. de Vries, Rutger J. Wierda, Peter J. van den Elsen, Pascalle S. Monraats, M.M. Ewing, B.T. Heijmans, P. Eline Slagboom, (unknown), Pieter A. Doevendans, R. A. Tio, Robbert J. de Winter, Moniek P.M. de Maat, Olga A. Iakoubova, (unknown), (unknown), Rudi G. J. Westendorp, J. Wouter Jukema, (unknown), (unknown)	2010	16
13	Epigenetic histone acetylation modifiers in vascular remodelling – new targets for therapy in cardiovascular disease Netherlands Heart Journal ·Douwe Pons, J. Wouter Jukema	2008	14
14	Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention Pharmacogenetics and Genomics ·Pascalle S. Monraats, Florentine de Vries, Laura W. de Jong, Douwe Pons, Varsha D. K. D. Sewgobind, Aeilko H. Zwinderman, Moniek P.M. de Maat, Leen M. ‘t Hart, Pieter A. Doevendans, Robbert J. de Winter, René A. Tio, Johannes Waltenberger, Rune R. Frants, Arnoud van der Laarse, Ernst E. van der Wall, J. Wouter Jukema	2006	13
15	The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions Thrombosis and Haemostasis ·Douwe Pons, Pascalle S. Monraats, Moniek P.M. de Maat, Nuno Pires, Paul H.A. Quax, Bart van Vlijmen, Frits Rosendaal, Aeilko H. Zwinderman, Pieter A. Doevendans, Johannes Waltenberger, Robbert de Winter, René A. Tio, Rune R. Frants, Arnoud van der Laarse, E. Wall, J. Wouter Jukema	2007	10
16	Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention Pharmacogenetics and Genomics ·Marcel A.M. Beijk, S. Matthijs Boekholdt, Saskia Z.H. Rittersma, Douwe Pons, Aeilko H. Zwinderman, Pieter A. Doevendans, René A. Tio, Jan G.P. Tijssen, J. Wouter Jukema, Robbert J. de Winter	2010	9
17	A genome wide association analysis in the GENDER study Netherlands Heart Journal ·M. Lourdes Sampietro, Douwe Pons, Peter de Knijff, P. Eline Slagboom, A. H. Zwinderman, J. Wouter Jukema	2009	9
18	Metabolic background determines the importance of NOS3 polymorphisms in restenosis after percutaneous coronary intervention: A study in patients with and without the metabolic syndrome. PubMed ·Douwe Pons, Pascalle S. Monraats, Aeilko H. Zwinderman, Moniek P.M. de Maat, Pieter A. Doevendans, Robbert J. de Winter, René A. Tio, Johannes Waltenberger, J. Wouter Jukema	2009	9
19	Variation in the CBP gene involved in epigenetic control associates with cognitive function Neurobiology of Aging ·Stella Trompet, Anton J.M. de Craen, J. Wouter Jukema, Douwe Pons, P. Eline Slagboom, Dennis Kremer, Eduard L. E. M. Bollen, Rudi G. J. Westendorp	2010	6
20	Metabolic Background Determines the Importance ofNOS3Polymorphisms in Restenosis after Percutaneous Coronary Intervention: A Study in Patients with and without the Metabolic Syndrome Disease Markers ·Douwe Pons, Pascalle S. Monraats, Aeilko H. Zwinderman, Moniek P.M. de Maat, Pieter A. Doevendans, Robbert J. de Winter, René A. Tio, Johannes Waltenberger, J. Wouter Jukema	2009	5

About Douwe Pons

Douwe Pons is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Cancer Research, Molecular Biology and Hematology, having authored 26 papers that have together received 653 indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (7 papers), Protease and Inhibitor Mechanisms (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Acute Myocardial Infarction Research (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Epigenetics and DNA Methylation (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). The work is most often cited by research in Nephrology (56 citations), Hematology (52 citations), Cancer Research (60 citations), Cardiology and Cardiovascular Medicine (81 citations) and Critical Care and Intensive Care Medicine (17 citations). Douwe Pons has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include J. Wouter Jukema, Paul H.A. Quax, F. R. de Vries, Peter J. van den Elsen, Bastiaan T. Heijmans, JM Tavaré, René A. Tio, Peter W. Mathieson, Moin A. Saleem and Rachel Lennon. Their work appears in journals such as Pharmacogenetics and Genomics, European Heart Journal, Disease Markers, Thrombosis and Haemostasis and Heart.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Douwe Pons

Impact in

Papers in i

In The Last Decade

Douwe Pons

Peers

Countries citing papers authored by Douwe Pons

Fields of papers citing papers by Douwe Pons

All Works

About Douwe Pons

Explore authors with similar magnitude of impact

Papers in